Taken together, most studies showed reduction in serum concentrations of OPG and RANKL in patients with NAFLD, whose pathophysiological explanation, if any, remains obscure. This evidence concerns the gene TNFRSF11B and metabolic dysfunction-associated steatotic liver disease.